Released: May 8, 2013
DEFENSE HEALTH PROGRAM
DEPARTMENT OF DEFENSE PEER REVIEWED CANCER RESEARCH PROGRAM
FUNDING OPPORTUNITIES FOR FISCAL YEAR 2013
The Fiscal Year 2013 (FY13) Defense Appropriation Act provides for $15 million to the Department of Defense (DoD) Peer Reviewed Cancer Research Program (PRCRP) to research cancers not addressed in breast, prostate, lung (excluding mesothelioma), and ovarian cancer research programs currently executed by the DoD U.S. Army Medical Research and Materiel Command (USAMRMC).
Congressionally Directed Topic Areas: To be considered for funding, applications for the FY13 PRCRP must address at least one of the Topic Areas as directed by Congress. Research applications in the areas of breast, prostate, lung (excluding mesothelioma), or ovarian cancer will not be accepted. The FY13 PRCRP Topic Areas are listed below:
- Blood cancers
- Colorectal cancer
- Genetic cancer research
- Kidney cancer
- Listeria vaccine for cancer
- Melanoma and other skin cancers
- Pancreatic cancer
- Pediatric brain tumors
New for FY13 – Military Relevance Focus Areas:
- Susceptibility to developing cancers due to exposure to militarily relevant environmental or chemical carcinogens (including transgenerational effects)
- Identification of predictive and prognostic biomarkers of developing cancers due to exposure to militarily relevant environmental or chemical carcinogens
- Molecular mechanisms by which environmental influences associated with military exposures alter gene structure, stability, and expression
- Examination of cancer diagnosis and prognosis effects on the psychosocial well-being of military beneficiaries
The PRCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY13 PRCRP Program Announcements and General Application Instructions for the following award mechanisms are anticipated to be posted on Grants.gov in May 2013. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.
|Award Mechanism||Eligibility||Key Mechanism Elements||Funding|
|Career Development Award||Principal Investigator: Independent investigator at the level of Assistant Professor, Instructor, or equivalent within 7 years of first faculty appointment (or equivalent) at the time of application deadline
Designated Collaborator: Investigators at or above the level of Associate Professor (or equivalent); must have a proven publication and funding record in at least one of the FY13 PRCRP Topic Areas. May not have a major research focus on breast, prostate, lung (excluding mesothelioma), or ovarian cancer
|Idea Award with Special Focus||Independent investigator at or above the level of Assistant Professor (or equivalent)||
All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be made available on the Grants.gov website. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government's single entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released. Requests for email notification of the Program Announcements release may be sent to email@example.com. Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.
For more information about the PRCRP or other CDMRP-sponsored programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Public Affairs, 301-619-9783